Ra Medical Systems, Inc. also files under VTAK; those filings are included.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Mar 26, 2026 | Jenkins David A | Chairman of the Board and CEO, Director | Grant(A) | 40K | — | $0 |
| Mar 26, 2026 | Caruso James Joseph | Director | Grant(A) | 40K | — | $0 |
| Mar 26, 2026 | Arno Andrew | Director | Grant(A) | 40K | — | $0 |
| Mar 26, 2026 | Anderson Philip J | Chief Financial Officer | Grant(A) | 40K | — | $0 |
| Mar 26, 2026 | Colombatto Martin J | Director | Grant(A) | 40K | — | $0 |
| Feb 12, 2026 | Jenkins David A | Chairman of the Board and CEO, Director | Other(J) | 7K | — | — |
| Feb 12, 2026 | Jenkins David A | Chairman of the Board and CEO, Director | Other(J) | 2K | — | — |
| Dec 31, 2025 | Jenkins David A | Chairman of the Board and CEO | Other(J) | 170K | $1.56 | $265K |
| Dec 31, 2025 | Jenkins David A | Chairman of the Board and CEO | Other(J) | 170K | $1.56 | $265K |
| Dec 5, 2025 | Jenkins David A | Chairman of the Board and CEO | Conversion(C) | 98 | — | $0 |
| Dec 5, 2025 | Jenkins David A | Chairman of the Board and CEO | Conversion(C) | 12K | — | $0 |
| Dec 5, 2025 | Jenkins David A | Chairman of the Board and CEO | Conversion(C) | 6K | — | $0 |
| Dec 5, 2025 | Jenkins David A | Chairman of the Board and CEO | Conversion(C) | 31K | — | $0 |
| Dec 5, 2025 | Jenkins David A | Chairman of the Board and CEO | Conversion(C) | 19 | — | $0 |
| Dec 5, 2025 | Jenkins David A | Chairman of the Board and CEO | Conversion(C) | 2K | — | $0 |
| Dec 5, 2025 | Caruso James Joseph | Director | Conversion(C) | 41 | — | $0 |
| Dec 5, 2025 | Caruso James Joseph | Director | Conversion(C) | 8 | — | $0 |
| Aug 12, 2025 | Arno Andrew | Director | Grant(A) | 50K | — | $0 |
| Aug 12, 2025 | Jenkins David A | Exec. Chairman of the Board, Director | Grant(A) | 500K | — | $0 |
| Aug 12, 2025 | Colombatto Martin J | Director | Grant(A) | 50K | — | $0 |
| Aug 12, 2025 | Caruso James Joseph | Director | Grant(A) | 50K | — | $0 |
| Jan 29, 2025 | Arno Andrew | Director | Grant(A) | 100K | — | $0 |
| Jan 29, 2025 | Caruso James Joseph | Director | Grant(A) | 100K | — | $0 |
| Jan 29, 2025 | Jacques Marie-Claude | Chief Commercial Officer | Grant(A) | 125K | — | $0 |
| Jan 29, 2025 | Jenkins David A | Chairman of the Board and CEO | Grant(A) | 450K | — | $0 |
| Jan 29, 2025 | Colombatto Martin J | Director | Sell(S) | 3 | $0.40 | $1 |
| Jan 29, 2025 | Colombatto Martin J | Director | Grant(A) | 100K | — | $0 |
| Jan 6, 2025 | Anderson Philip J | Chief Financial Officer | Grant(A) | 500K | — | $0 |
| May 1, 2024 | Jacques Marie-Claude | Chief Commercial Officer | Grant(A) | 250K | — | $0 |
| Jan 23, 2024 | Jenkins David A | Executive Chairman and CEO, Director | Buy(P) | 10K | $0.60 | $6K |
| Jan 22, 2024 | Jenkins David A | Executive Chairman and CEO, Director | Buy(P) | 10K | $0.43 | $4K |
| Jan 19, 2024 | Jenkins David A | Executive Chairman and CEO, Director | Buy(P) | 8K | $0.42 | $4K |
| Jan 18, 2024 | Jenkins David A | Executive Chairman and CEO, Director | Buy(P) | 8K | $0.41 | $3K |
| Jan 16, 2024 | Jenkins David A | Executive Chairman and CEO, Director | Buy(P) | 8K | $0.39 | $3K |
| Jan 16, 2024 | Jenkins David A | Executive Chairman and CEO, Director | Buy(P) | 8K | $0.39 | $3K |
| Jan 8, 2024 | Caruso James Joseph | Director | Grant(A) | 25K | — | $0 |
| Jan 8, 2024 | Colombatto Martin J | Director | Grant(A) | 25K | — | $0 |
| Jan 8, 2024 | Thomassen Margrit | Interim CFO and Secretary | Grant(A) | 25K | — | $0 |
| Jan 8, 2024 | Francis, John P. | Director | Grant(A) | 25K | — | $0 |
| Mar 23, 2023 | Meline Susanne | Director | Conversion(C) | 3 | — | $0 |
| Mar 23, 2023 | Jenkins David A | Ex. Chairman of the Board, Director | Conversion(C) | 2K | — | $0 |
| Mar 23, 2023 | Jenkins David A | Ex. Chairman of the Board, Director | Conversion(C) | 710K | — | $0 |
| Mar 23, 2023 | Jenkins David A | Ex. Chairman of the Board, Director | Conversion(C) | 278 | — | $0 |
| Mar 23, 2023 | Jenkins David A | Ex. Chairman of the Board, Director | Conversion(C) | 710 | — | $0 |
| Mar 23, 2023 | Jenkins David A | Ex. Chairman of the Board, Director | Conversion(C) | 2 | — | $0 |
| Mar 23, 2023 | Caruso James Joseph | Director | Conversion(C) | 2K | — | $0 |
| Mar 23, 2023 | Caruso James Joseph | Director | Conversion(C) | 2 | — | $0 |
| Mar 23, 2023 | Meline Susanne | Director | Conversion(C) | 3K | — | $0 |
| Mar 23, 2023 | Jenkins David A | Ex. Chairman of the Board, Director | Conversion(C) | 278K | — | $0 |
| Jan 9, 2023 | Jenkins David A | Executive Chairman of Board, Director | Grant(A) | 3K | — | — |
| Jan 9, 2023 | Jenkins David A | Executive Chairman of Board, Director | Grant(A) | 7K | — | — |
| Jan 9, 2023 | Jenkins David A | Executive Chairman of Board, Director | Grant(A) | 21 | — | — |
| Jan 9, 2023 | Caruso James Joseph | Director | Grant(A) | 10 | — | — |
| Jan 9, 2023 | Meline Susanne | Director | Grant(A) | 14 | — | $0 |
| Nov 20, 2022 | McGuire Jonathan Will | CEO & Secretary, Director | Tax withholding(F) | 84 | $2.67 | $224 |
| May 20, 2022 | Jackson Andrew C. | CFO | Tax withholding(F) | 1K | $0.30 | $408 |
| May 20, 2022 | McGuire Jonathan Will | Chief Executive Officer, Director | Tax withholding(F) | 4K | $0.30 | $1K |
| Nov 22, 2021 | McGuire Jonathan Will | Chief Executive Officer, Director | Sell(S) | 8K | $2.62 | $21K |
| Nov 22, 2021 | Jackson Andrew C. | CFO | Sell(S) | 3K | $2.62 | $7K |
| Nov 20, 2021 | Jackson Andrew C. | CFO | Disposed to issuer(D) | 12K | — | $0 |
| Nov 20, 2021 | McGuire Jonathan Will | Chief Executive Officer, Director | Disposed to issuer(D) | 35K | — | $0 |
| Jun 4, 2021 | Mejia Richard Jr | Director | Grant(A) | 4K | — | $0 |
| Jun 4, 2021 | Colombatto Martin J | Director | Grant(A) | 4K | — | $0 |
| Jun 4, 2021 | Enquist William R | Director | Grant(A) | 4K | — | $0 |
| Jun 4, 2021 | Stafslien Joan | Director | Grant(A) | 4K | — | $0 |
| Jun 4, 2021 | Meline Susanne | Director | Grant(A) | 4K | — | $0 |
| May 20, 2021 | McGuire Jonathan Will | Chief Executive Officer, Director | Tax withholding(F) | 216 | $3.15 | $680 |
| Feb 3, 2021 | Meline Susanne | Director | Grant(A) | 4K | — | $0 |
| Jan 5, 2021 | Enquist William R | Director | Grant(A) | 7K | — | $0 |
| Jan 5, 2021 | Colombatto Martin J | Director | Grant(A) | 10K | — | $0 |
| Jan 5, 2021 | Saad Mark E | Director | Grant(A) | 8K | — | $0 |
| Jan 5, 2021 | Mejia Richard Jr | Director | Grant(A) | 9K | — | $0 |
| Nov 20, 2020 | McGuire Jonathan Will | Chief Executive Officer, Director | Tax withholding(F) | 216 | $6.39 | $1K |
| Nov 20, 2020 | Jackson Andrew C. | CFO | Grant(A) | 200 | $5.43 | $1K |
| Nov 20, 2020 | Horwood Daniel | General Counsel | Grant(A) | 200 | $5.43 | $1K |
| Nov 20, 2020 | Kraws Jeffrey J | Co-President | Grant(A) | 200 | $5.43 | $1K |
| Nov 19, 2020 | Colombatto Martin J | Director | Buy(P) | 9K | $5.78 | $50K |
| Nov 19, 2020 | Stafslien Joan | Director | Buy(P) | 4K | $5.67 | $25K |
| Nov 19, 2020 | Mejia Richard Jr | Director | Buy(P) | 1K | $5.82 | $6K |
| Nov 19, 2020 | Enquist William R | Director | Buy(P) | 5K | $5.82 | $31K |
| Nov 17, 2020 | McGuire Jonathan Will | Chief Executive Officer, Director | Grant(A) | 104K | — | $0 |
| Nov 17, 2020 | Jackson Andrew C. | CFO | Grant(A) | 35K | — | $0 |
| Nov 17, 2020 | Horwood Daniel | General Counsel | Grant(A) | 20K | — | $0 |
| Oct 12, 2020 | Saad Mark E | Director | Grant(A) | 100K | — | $0 |
| Oct 12, 2020 | Colombatto Martin J | Director | Grant(A) | 100K | — | $0 |
| Oct 12, 2020 | Mejia Richard Jr | Director | Grant(A) | 100K | — | $0 |
| Oct 12, 2020 | Enquist William R | Director | Grant(A) | 100K | — | $0 |
| Oct 12, 2020 | Stafslien Joan | Director | Grant(A) | 100K | — | $0 |
| Aug 3, 2020 | McGuire Jonathan Will | Chief Executive Officer, Director | Buy(P) | 10K | — | $0 |
| Aug 3, 2020 | Horwood Daniel | General Counsel | Buy(P) | 10K | $0.35 | $4K |
| Aug 3, 2020 | Horwood Daniel | General Counsel | Buy(P) | 10K | — | $0 |
| Aug 3, 2020 | Jackson Andrew C. | CFO | Buy(P) | 10K | $0.35 | $4K |
| Aug 3, 2020 | Jackson Andrew C. | CFO | Buy(P) | 10K | — | $0 |
| Aug 3, 2020 | Kraws Jeffrey J | Co-President | Buy(P) | 10K | $0.35 | $4K |
| Aug 3, 2020 | Kraws Jeffrey J | Co-President | Buy(P) | 10K | — | $0 |
| Aug 3, 2020 | McGuire Jonathan Will | Chief Executive Officer, Director | Buy(P) | 10K | $0.35 | $4K |
| Jun 12, 2020 | Mejia Richard Jr | Director | Buy(P) | 50K | $0.60 | $30K |
| May 29, 2020 | Enquist William R | Director | Buy(P) | 50K | $0.47 | $24K |
| May 22, 2020 | McGuire Jonathan Will | Chief Executive Officer, Director | Buy(P) | 10K | $0.46 | $5K |
| May 22, 2020 | Jackson Andrew C. | CFO | Buy(P) | 10K | $0.46 | $5K |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Issuer: Ra Medical Systems, Inc., SEC CIK 0001716621. The symbol on a Form 4 is typed by the filer, so this page follows the issuer with the newest filing under RMED and shows every filing by that issuer (also filed as VTAK).
Coverage: Form 4 filings indexed 2006-01-02 → 2026-09-05. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).
Connected pages for RMED